← Leaderboards
Francesca Torriani
University Of California San Diego
$10,341
Attributed
$10,341
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$10,341 · 2
By mechanism
M01$10,341 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Jerrold M Olefsky$29,583,289
- R Jeffrey Chang$12,222,781
- Robert Roy Henry$4,115,619
- William L. Nyhan$92,539
- Elizabeth L Barrett-Connor$23,063,939
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationClinical ResearchHiv InfectionsDrug Adverse EffectDrug Screening /EvaluationEfavirenzGlucose Tolerance TestHyperinsulinismHyperlipidemiaInsulin Sensitivity /ResistanceLipodystrophyMedical ComplicationMetabolism DisorderMetforminObesityOutcomes ResearchAidsRosiglitazoneAids TherapyCombination ChemotherapyComorbidity
Grant awards (11)
ACTG A5082 METFORMIN AND ROSIGLITAZONE IN HIV SUBJECTS WITH HYPERINSULINEMIA$1,567
M01 · FY2005 · RR
Metformin and Rosiglitazone in HIV with Hyperinsulinemia$8,774
M01 · FY2004 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2002 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2002 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2002 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2002 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2001 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2001 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2000 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2000 · RR
EFAVIRENZ FOR CARDIAC RISK DUE TO HIV METABOLIC DISORDER$0
M01 · FY2000 · RR